Lori Lynn Austin, MD | |
128 N Whitney Ave, Cookeville, TN 38501-2493 | |
(931) 783-4600 | |
(931) 783-4699 |
Full Name | Lori Lynn Austin |
---|---|
Gender | Female |
Speciality | Internal Medicine |
Experience | 27 Years |
Location | 128 N Whitney Ave, Cookeville, Tennessee |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1336133248 | NPI | - | NPPES |
1510890 | Medicaid | TN | |
3723270 | Medicaid | TN | |
3850359 | Medicaid | TN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 33892 (Tennessee) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Amedisys Home Health | Livingston, TN | Home health agency |
Nhc Homecare Murfreesboro | Murfreesboro, TN | Home health agency |
Quality Home Health | Jamestown, TN | Home health agency |
Deaconess Homecare 1 | Mount juliet, TN | Home health agency |
Cookeville Regional Medical Center | Cookeville, TN | Hospital |
Vanderbilt University Medical Center | Nashville, TN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Summit Medical Group, Pllc | 2860396330 | 485 |
News Archive
Endurance sport does not only change the condition and fitness of muscles but also simultaneously improves the neuronal connections to the muscle fibers based on a muscle-induced feedback.
A new treatment that involves editing DNA has been used for the first time at Great Ormond Street Hospital to successfully treat drug-resistant leukaemia.
National Jewish Health researchers have received nearly $13 million from the National Institutes of Health to evaluate potential rescue medications for victims of terrorist attacks, wartime use of toxic gases, and/or inhalation disasters. The gases of greatest interest in these studies will be 'mustard gas' (sulfur mustard) and chlorine gas.
Oxford BioMedica plc, the leading gene-based biopharmaceutical company, today announces that the US Food and Drug Administration has approved its Investigational New Drug application for the Phase I/IIa clinical development of UshStat, a novel gene-based treatment for Usher syndrome type 1B.
Masimo, the inventor of Pulse CO-Oximetry™ and Measure-Through Motion and Low Perfusion pulse oximetry, announced today that a new cost-effectiveness study shows that implementation of the Masimo Patient SafetyNet remote monitoring and clinician notification system with Masimo SET pulse oximetry saved one hospital $817,000 in its first year.
› Verified 9 days ago
Entity Name | Summit Medical Group, Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1659090298 PECOS PAC ID: 2860396330 Enrollment ID: O20031125000793 |
News Archive
Endurance sport does not only change the condition and fitness of muscles but also simultaneously improves the neuronal connections to the muscle fibers based on a muscle-induced feedback.
A new treatment that involves editing DNA has been used for the first time at Great Ormond Street Hospital to successfully treat drug-resistant leukaemia.
National Jewish Health researchers have received nearly $13 million from the National Institutes of Health to evaluate potential rescue medications for victims of terrorist attacks, wartime use of toxic gases, and/or inhalation disasters. The gases of greatest interest in these studies will be 'mustard gas' (sulfur mustard) and chlorine gas.
Oxford BioMedica plc, the leading gene-based biopharmaceutical company, today announces that the US Food and Drug Administration has approved its Investigational New Drug application for the Phase I/IIa clinical development of UshStat, a novel gene-based treatment for Usher syndrome type 1B.
Masimo, the inventor of Pulse CO-Oximetry™ and Measure-Through Motion and Low Perfusion pulse oximetry, announced today that a new cost-effectiveness study shows that implementation of the Masimo Patient SafetyNet remote monitoring and clinician notification system with Masimo SET pulse oximetry saved one hospital $817,000 in its first year.
› Verified 9 days ago
Entity Name | Saint Thomas Medical Partners |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1437194669 PECOS PAC ID: 1557269354 Enrollment ID: O20031230000470 |
News Archive
Endurance sport does not only change the condition and fitness of muscles but also simultaneously improves the neuronal connections to the muscle fibers based on a muscle-induced feedback.
A new treatment that involves editing DNA has been used for the first time at Great Ormond Street Hospital to successfully treat drug-resistant leukaemia.
National Jewish Health researchers have received nearly $13 million from the National Institutes of Health to evaluate potential rescue medications for victims of terrorist attacks, wartime use of toxic gases, and/or inhalation disasters. The gases of greatest interest in these studies will be 'mustard gas' (sulfur mustard) and chlorine gas.
Oxford BioMedica plc, the leading gene-based biopharmaceutical company, today announces that the US Food and Drug Administration has approved its Investigational New Drug application for the Phase I/IIa clinical development of UshStat, a novel gene-based treatment for Usher syndrome type 1B.
Masimo, the inventor of Pulse CO-Oximetry™ and Measure-Through Motion and Low Perfusion pulse oximetry, announced today that a new cost-effectiveness study shows that implementation of the Masimo Patient SafetyNet remote monitoring and clinician notification system with Masimo SET pulse oximetry saved one hospital $817,000 in its first year.
› Verified 9 days ago
Entity Name | Cookeville Regional Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1649202102 PECOS PAC ID: 8325092638 Enrollment ID: O20050309000874 |
News Archive
Endurance sport does not only change the condition and fitness of muscles but also simultaneously improves the neuronal connections to the muscle fibers based on a muscle-induced feedback.
A new treatment that involves editing DNA has been used for the first time at Great Ormond Street Hospital to successfully treat drug-resistant leukaemia.
National Jewish Health researchers have received nearly $13 million from the National Institutes of Health to evaluate potential rescue medications for victims of terrorist attacks, wartime use of toxic gases, and/or inhalation disasters. The gases of greatest interest in these studies will be 'mustard gas' (sulfur mustard) and chlorine gas.
Oxford BioMedica plc, the leading gene-based biopharmaceutical company, today announces that the US Food and Drug Administration has approved its Investigational New Drug application for the Phase I/IIa clinical development of UshStat, a novel gene-based treatment for Usher syndrome type 1B.
Masimo, the inventor of Pulse CO-Oximetry™ and Measure-Through Motion and Low Perfusion pulse oximetry, announced today that a new cost-effectiveness study shows that implementation of the Masimo Patient SafetyNet remote monitoring and clinician notification system with Masimo SET pulse oximetry saved one hospital $817,000 in its first year.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Lori Lynn Austin, MD 140 W 7th St, Cookeville, TN 38501-1726 Ph: (931) 783-5582 | Lori Lynn Austin, MD 128 N Whitney Ave, Cookeville, TN 38501-2493 Ph: (931) 783-4600 |
News Archive
Endurance sport does not only change the condition and fitness of muscles but also simultaneously improves the neuronal connections to the muscle fibers based on a muscle-induced feedback.
A new treatment that involves editing DNA has been used for the first time at Great Ormond Street Hospital to successfully treat drug-resistant leukaemia.
National Jewish Health researchers have received nearly $13 million from the National Institutes of Health to evaluate potential rescue medications for victims of terrorist attacks, wartime use of toxic gases, and/or inhalation disasters. The gases of greatest interest in these studies will be 'mustard gas' (sulfur mustard) and chlorine gas.
Oxford BioMedica plc, the leading gene-based biopharmaceutical company, today announces that the US Food and Drug Administration has approved its Investigational New Drug application for the Phase I/IIa clinical development of UshStat, a novel gene-based treatment for Usher syndrome type 1B.
Masimo, the inventor of Pulse CO-Oximetry™ and Measure-Through Motion and Low Perfusion pulse oximetry, announced today that a new cost-effectiveness study shows that implementation of the Masimo Patient SafetyNet remote monitoring and clinician notification system with Masimo SET pulse oximetry saved one hospital $817,000 in its first year.
› Verified 9 days ago
Scott F Reising, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 228 W. 4th Street, Suite 200, Cookeville, TN 38501 Phone: 931-372-0405 Fax: 931-372-0463 | |
Stacy David Brewington, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 228 W. 4th Street, Suite 200, Cookeville, TN 38501 Phone: 931-372-0405 Fax: 931-372-0463 | |
Mark Arden Pierce, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 145 W 4th St, Suite 201, Cookeville, TN 38501 Phone: 931-783-2902 Fax: 931-783-2219 | |
Michael Blaine Lenhart, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 228 West 4th St, Suite 200, Cookeville, TN 38501 Phone: 931-372-0405 Fax: 931-372-0463 | |
Dr. Toney Britton Hudson, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 315 N Washington Ave, Ste 165, Cookeville, TN 38501 Phone: 931-526-1604 Fax: 931-526-7378 | |
James Chike Ezi-ashi, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 438 N Whitney Ave, Cookeville, TN 38501 Phone: 931-783-2616 Fax: 931-783-2610 | |
Dr. Brian Keith Dockery, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 228 W 4th St, Suite 200, Cookeville, TN 38501 Phone: 931-372-0405 Fax: 931-372-0463 |